Home › Asset managers › Gabelli › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Gabelli voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
483 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Gabelli voted | Funds |
|---|---|---|---|---|---|---|---|
| LANTHEUS HOLDINGS, INC. | April 30, 2026 | The approval of the Lantheus Holdings, Inc. Amended and Restated 2026 Equity Incentive Plan. | Compensation | Board | ABSTAIN | 1 | |
| LENNAR CORPORATION | April 8, 2026 | Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending November 30, 2026. | Audit-related | Board | AGAINST | 1 | |
| LIONSGATE STUDIOS CORP. | March 17, 2026 | Election of Directors: Emily Fine | Director Elections | Board | WITHHOLD | 1 | |
| LIONSGATE STUDIOS CORP. | March 17, 2026 | Election of Directors: Richard Rosenblatt | Director Elections | Board | WITHHOLD | 1 | |
| LIONSGATE STUDIOS CORP. | March 17, 2026 | Election of Directors: Yvette Ostolaza | Director Elections | Board | WITHHOLD | 1 | |
| MADRIGAL PHARMACEUTICALS INC. | June 17, 2026 | Approval of Madrigal Pharmaceuticals, Inc. 2026 Stock Plan | Compensation | Board | AGAINST | 1 | |
| MARINEMAX, INC. | March 3, 2026 | To approve the amendment of our 2021 Stock-Based Compensation Plan to increase the number of shares available for issuance by 415,000 shares. | Compensation | Board | ABSTAIN | 1 | |
| MASTERCARD INCORPORATED | June 16, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Mastercard for 2026 | Audit-related | Board | AGAINST | 1 | |
| MATTEL, INC. | May 28, 2026 | Approval of the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan. | Compensation | Board | AGAINST | 1 | |
| MEDALLION FINANCIAL CORP. | June 9, 2026 | Proposal to approve a non-binding advisory resolution to approve the 2025 compensation of Medallion Financial Corp.'s named executive officers, as described in the proxy statement. | Say-on-Pay | Board | ABSTAIN | 1 | |
| MEDTRONIC PLC | October 16, 2025 | Renewing the Board of Directors' authority to opt out of pre- emption rights under Irish law; | Capital Structure | Board | AGAINST | 1 | |
| MERCK & CO., INC. | May 26, 2026 | Ratification of the appointment of the Company's independent registered public accounting firm for 2026. | Audit-related | Board | AGAINST | 1 | |
| MGM CHINA HOLDINGS LTD | May 14, 2026 | TO ADD THE TOTAL NUMBER OF THE SHARES WHICH ARE REPURCHASED UNDER THE GENERAL MANDATE IN RESOLUTION (6) TO THE TOTAL NUMBER OF THE SHARES WHICH MAY BE ISSUED UNDER THE GENERAL MANDATE IN RESOLUTION (5) | Capital Structure | Board | AGAINST | 1 | |
| MGM CHINA HOLDINGS LTD | May 14, 2026 | TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH ADDITIONAL SHARES (INCLUDING ANY SALE OR TRANSFER OF TREASURY SHARES OUT OF TREASURY) OF THE COMPANY NOT EXCEEDING 20% OF THE TOTAL NUMBER OF ISSUED SHARES (EXCLUDING ANY TREASURY SHARES) AT THE DATE OF PASSING THIS RESOLUTION | Capital Structure | Board | AGAINST | 1 | |
| MICROSOFT CORPORATION | December 5, 2025 | Ratification of the Selection of Deloitte & Touche LLP as our Independent Auditor for Fiscal Year 2026 | Audit-related | Board | AGAINST | 1 | |
| MODERNA, INC. | November 12, 2025 | To approve a one-time stock option exchange program for non- Executive Committee employees of Moderna, Inc. (the "Option Exchange Proposal"). | Capital Structure | Board | AGAINST | 1 | |
| MONDELEZ INTERNATIONAL, INC. | May 20, 2026 | Shareholder proposal requesting a report on objective evaluation of plastics packaging policies | Environment or Climate | Shareholder | Against | FOR | 1 |
| MORGAN STANLEY | May 14, 2026 | To ratify the appointment of Deloitte & Touche LLP as independent auditor | Audit-related | Board | AGAINST | 1 | |
| NASDAQ, INC. | June 10, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 | Audit-related | Board | AGAINST | 1 | |
| NEKTAR THERAPEUTICS | June 4, 2026 | To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares. | Compensation | Board | AGAINST | 1 | |
| NEUROCRINE BIOSCIENCES, INC. | May 27, 2026 | To approve an amendment of the Company's 2025 Equity Incentive Plan to increase the aggregate number of shares of common stock reserved for issuance thereunder by 4,000,000 shares; and | Compensation | Board | ABSTAIN | 1 | |
| NEW HOPE CORPORATION LTD | November 20, 2025 | APPROVAL OF THE COMPANYS RIGHTS PLAN | Compensation | Board | AGAINST | 1 | |
| NEW JERSEY RESOURCES CORPORATION | January 21, 2026 | To approve the 2026 Stock Award and Incentive Plan. | Compensation | Board | ABSTAIN | 1 | |
| NISSIN FOODS COMPANY LIMITED | June 3, 2026 | TO EXTEND THE GENERAL MANDATE TO BE GIVEN TO THE DIRECTORS TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES OF AN AMOUNT REPRESENTING THE TOTAL NUMBER OF SHARES BOUGHT BACK BY THE COMPANY | Capital Structure | Board | AGAINST | 1 | |
| NISSIN FOODS COMPANY LIMITED | June 3, 2026 | TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO ISSUE NEW SHARES NOT EXCEEDING 20% OF THE TOTAL NUMBER OF ISSUED SHARES OF THE COMPANY | Capital Structure | Board | AGAINST | 1 | |
| NOVUS HOLDINGS LIMITED | August 22, 2025 | ENDORSEMENT OF THE REMUNERATION POLICY | Compensation | Board | AGAINST | 1 | |
| NOVUS HOLDINGS LIMITED | August 22, 2025 | RE-ELECTION OF NON-EXECUTIVE DIRECTOR - ADRIAN STEVEN ZETLER | Director Elections | Board | AGAINST | 1 | |
| NVIDIA CORPORATION | June 24, 2026 | Ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2027. | Audit-related | Board | AGAINST | 1 | |
| ORACLE CORPORATION | November 18, 2025 | Ratification of the Selection of our Independent Registered Public Accounting Firm | Audit-related | Board | AGAINST | 1 | |
| OTIS WORLDWIDE CORPORATION | May 27, 2026 | Shareholder proposal regarding reporting on political contributions and expenditures | Other Social Issues | Shareholder | Against | FOR | 1 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | June 3, 2026 | To approve the amendment of our 2020 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| PEPSICO, INC. | May 6, 2026 | Ratification of appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2025. | Audit-related | Board | AGAINST | 1 | |
| PROLOGIS, INC. | April 28, 2026 | Ratification of the Appointment of KPMG LLP as the Company's Independent Registered Public Accounting Firm for the Year 2026. | Audit-related | Board | AGAINST | 1 | |
| PT TELKOM INDONESIA (PERSERO) TBK | June 8, 2026 | Determination of Public Accountant and/or Public Accounting Firm to Audit the Company's Consolidated Financial Statement and Company's Financial Report of the Micro and Small Business Funding Program (MSBF) for Financial Year of 2026. | Audit-related | Board | ABSTAIN | 1 | |
| RADNET, INC. | June 2, 2026 | The approval of an amendment and restatement to the Company's Equity Incentive Plan. | Compensation | Board | ABSTAIN | 1 | |
| REGENERON PHARMACEUTICALS, INC. | June 12, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Audit-related | Board | AGAINST | 1 | |
| REGENXBIO INC. | May 29, 2026 | To approve a stock option exchange for our executive employees. | Compensation | Board | AGAINST | 1 | |
| REGENXBIO INC. | May 29, 2026 | To approve a stock option exchange for our non-executive employees. | Compensation | Board | AGAINST | 1 | |
| ROCKWELL AUTOMATION, INC. | February 10, 2026 | To approve the selection of Deloitte & Touche LLP as the Corporation's independent registered public accounting firm for fiscal 2026. | Audit-related | Board | AGAINST | 1 | |
| SEMPRA | May 12, 2026 | Ratification of appointment of independent registered public accounting firm. | Audit-related | Board | AGAINST | 1 | |
| SIGMAROC PLC | April 30, 2026 | TO DISAPPLY STATUTORY PRE-EMPTION RIGHTS | Capital Structure | Board | ABSTAIN | 1 | |
| SPIRE HEALTHCARE GROUP PLC | May 14, 2026 | AUTHORISE ISSUE OF EQUITY WITHOUT PRE-EMPTIVE RIGHTS | Capital Structure | Board | ABSTAIN | 1 | |
| STELLANTIS N.V. | April 14, 2026 | Delegation to the Board of Directors of the authority to issue shares in the capital of the Company and to limit or to exclude pre- emptive rights: Proposal to designate the Board of Directors as the corporate body authorized to issue common shares and to grant rights to subscribe for common shares as provided for in article 7 of the Company's articles of association | Capital Structure | Board | ABSTAIN | 1 | |
| STMICROELECTRONICS N.V. | May 27, 2026 | Delegation to the Supervisory Board of the authority to issue new common shares, to grant rights to subscribe for such shares, and to limit and/or exclude existing shareholders' pre-emptive rights on common shares, until the conclusion of the Company's 2027 Annual General Meeting | Capital Structure | Board | ABSTAIN | 1 | |
| STV GROUP PLC | June 5, 2026 | TO APPROVE THE GRANT OF A ONE-OFF SHARE OPTION IN 2026 TO THE CHAIRMAN OF THE COMPANY | Compensation | Board | ABSTAIN | 1 | |
| STV GROUP PLC | June 5, 2026 | TO APPROVE THE RULES OF THE STV GROUP PLC SHARE OPTION PLAN 2026 | Compensation | Board | ABSTAIN | 1 | |
| STV GROUP PLC | June 5, 2026 | TO AUTHORISE THE DIRECTORS TO DISAPPLY STATUTORY PRE-EMPTION RIGHTS IN RESPECT OF 5 PERCENT OF THE COMPANY'S ISSUED SHARE CAPITAL | Capital Structure | Board | ABSTAIN | 1 | |
| SUN ART RETAIL GROUP LTD | August 14, 2025 | TO EXTEND THE GENERAL MANDATE GRANTED TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH ADDITIONAL SHARES (INCLUDING ANY SALE OR TRANSFER OF TREASURY SHARES HELD UNDER THE NAME OF THE COMPANY) IN THE CAPITAL OF THE COMPANY BY THE AGGREGATE NUMBER OF THE SHARES BOUGHT BACK BY THE COMPANY | Capital Structure | Board | AGAINST | 1 | |
| SUN ART RETAIL GROUP LTD | August 14, 2025 | TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY (INCLUDING ANY SALE OR TRANSFER OF TREASURY SHARES HELD UNDER THE NAME OF THE COMPANY) NOT EXCEEDING 20% OF THE TOTAL NUMBER OF ISSUED SHARES (EXCLUDING TREASURY SHARES, IF ANY) OF THE COMPANY AS AT THE DATE OF PASSING OF THIS RESOLUTION | Capital Structure | Board | AGAINST | 1 | |
| SUN ART RETAIL GROUP LTD | August 14, 2025 | TO RE-ELECT MR. YIH LAI TAK, DIETER AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR | Director Elections | Board | AGAINST | 1 | |
| SUN ART RETAIL GROUP LTD | August 14, 2025 | TO RE-ELECT MS. GUANNAN WANG AS A NON-EXECUTIVE DIRECTOR | Director Elections | Board | AGAINST | 1 | |
| SUN ART RETAIL GROUP LTD | August 14, 2025 | TO RE-ELECT MS. MENGXUE MEI AS A NON-EXECUTIVE DIRECTOR | Director Elections | Board | AGAINST | 1 | |
| SUNRISE COMMUNICATIONS AG | May 7, 2026 | ADVISORY VOTE ON THE COMPENSATION REPORT 2025 | Say-on-Pay | Board | ABSTAIN | 1 | |
| SYNDAX PHARMACEUTICALS, INC | June 10, 2026 | To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| TECHNIPFMC PLC | May 1, 2026 | As a special resolution - Authority to Allot Equity Securities without Pre-emptive Rights: Pursuant to the authority contemplated by the resolution in Proposal 9, to authorize the Board to allot equity securities without pre-emptive rights. | Capital Structure | Board | AGAINST | 1 | |
| TENCENT HOLDINGS LTD | May 13, 2026 | TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ISSUE NEW SHARES (ORDINARY RESOLUTION 5 AS SET OUT IN THE NOTICE OF THE AGM) | Capital Structure | Board | AGAINST | 1 | |
| TEXAS INSTRUMENTS INCORPORATED | April 16, 2026 | Board proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. | Audit-related | Board | AGAINST | 1 | |
| THE CHARLES SCHWAB CORPORATION | May 21, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for 2026 | Audit-related | Board | AGAINST | 1 | |
| THE CIGNA GROUP | April 22, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2026 | Audit-related | Board | AGAINST | 1 | |
| THE COCA-COLA COMPANY | April 29, 2026 | Ratify the appointment of Ernst & Young LLP as Independent Auditors of the Company to serve for the 2026 fiscal year | Audit-related | Board | AGAINST | 1 | |
| THE MAGNUM ICE CREAM COMPANY N.V. | May 7, 2026 | Proposal to authorise the Board to restrict or exclude pre- emption rights in connection with the authorisations referred to in item 7(a) | Capital Structure | Board | ABSTAIN | 1 | |
| THE TJX COMPANIES, INC. | June 9, 2026 | Ratification of appointment of PricewaterhouseCoopers as TJX's independent registered public accounting firm for fiscal 2027 | Audit-related | Board | AGAINST | 1 | |
| THE TRADE DESK, INC. | September 16, 2025 | The approval of the amendment and restatement of the articles of incorporation of The Trade Desk, Inc. to change the date all of the shares of Class B common stock will automatically convert into Class A common stock and to waive jury trials for internal actions in conformity with recent Nevada law updates. | Capital Structure | Board | AGAINST | 1 | |
| THE WALT DISNEY COMPANY | March 18, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for fiscal 2026. | Audit-related | Board | AGAINST | 1 | |
| THE WENDY'S COMPANY | May 20, 2026 | Approve an amendment to the Company's 2020 Omnibus Award Plan to increase the number of shares of common stock available for issuance under the plan. | Compensation | Board | AGAINST | 1 | |
| TRAVERE THERAPEUTICS, INC. | May 19, 2026 | To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. | Compensation | Board | ABSTAIN | 1 | |
| TRINITY INDUSTRIES, INC. | May 21, 2026 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board | ABSTAIN | 1 | |
| TRUIST FINANCIAL CORPORATION | April 28, 2026 | Approval of the amendment and restatement of the Truist Financial Corporation 2022 Incentive Plan. | Compensation | Board | ABSTAIN | 1 | |
| UNION PACIFIC CORPORATION | May 14, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for 2026. | Audit-related | Board | AGAINST | 1 | |
| UNIQURE N.V. | June 10, 2026 | Designation of the Board as the competent body to exclude or limit preemptive rights upon the issuance of Ordinary Shares. | Capital Structure | Board | AGAINST | 1 | |
| UNIQURE N.V. | June 10, 2026 | Resolution to adopt the Amendment and Restatement of the 2014 Share Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| UNITED UTILITIES GROUP PLC | July 18, 2025 | TO DISAPPLY STATUTORY PRE-EMPTION RIGHTS | Capital Structure | Board | ABSTAIN | 1 | |
| VIASAT, INC. | September 4, 2025 | Amendment and Restatement of the 1996 Equity Participation Plan | Compensation | Board | AGAINST | 1 | |
| VODAFONE GROUP PLC | July 29, 2025 | TO AUTHORISE THE DIRECTORS TO DIS-APPLY PRE- EMPTION RIGHTS | Capital Structure | Board | ABSTAIN | 1 | |
| WASTE MANAGEMENT, INC. | May 12, 2026 | Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2026. | Audit-related | Board | AGAINST | 1 | |
| WELLTOWER INC. | May 21, 2026 | The approval, on an advisory basis, of the compensation of the named executive officers. | Say-on-Pay | Board | ABSTAIN | 1 | |
| WESTAIM CORP | May 19, 2026 | TO CONFIRM AND APPROVE THE AMENDED AND RESTATED LONG-TERM EQUITY INCENTIVE PLAN OF THE CORPORATION, AS REQUIRED BY THE TSX VENTURE EXCHANGE ON AN ANNUAL BASIS | Compensation | Board | ABSTAIN | 1 | |
| WEX INC. | May 5, 2026 | The Company's proposal to approve on an advisory (non-binding) basis the compensation of the Company's Named Executive Officers. | Say-on-Pay | Board | ABSTAIN | 1 | |
| WILLIS TOWERS WATSON PLC | May 20, 2026 | Renew the Board's existing authority to opt out of statutory pre- emption rights under Irish law. | Capital Structure | Board | AGAINST | 1 | |
| WOODSIDE ENERGY GROUP LTD | April 23, 2026 | Approval of Grant of FY26 LTI Award to CEO & Managing Director | Capital Structure | Board | ABSTAIN | 1 | |
| WYNN MACAU LTD | May 28, 2026 | TO EXTEND THE GENERAL MANDATE GRANTED TO THE DIRECTORS OF THE COMPANY TO ALLOT, ISSUE AND DEAL WITH NEW SHARES OF THE COMPANY BY THE AGGREGATE NUMBER OF SHARES REPURCHASED BY THE COMPANY | Capital Structure | Board | AGAINST | 1 | |
| WYNN MACAU LTD | May 28, 2026 | TO GRANT A GENERAL MANDATE TO THE DIRECTORS OF THE COMPANY TO ALLOT, ISSUE AND DEAL WITH NEW SHARES OF THE COMPANY NOT EXCEEDING 20% OF THE TOTAL NUMBER OF ISSUED SHARES (INCLUDING ANY RESELL OR TRANSFER OF TREASURY SHARES HELD UNDER THE NAME OF THE COMPANY) OF THE COMPANY AS AT THE DATE OF PASSING OF THIS RESOLUTION (EXCLUDING TREASURY SHARES) | Capital Structure | Board | AGAINST | 1 | |
| XENON PHARMACEUTICALS INC | June 2, 2026 | To approve the Corporation's 2026 Equity Incentive Plan; | Compensation | Board | ABSTAIN | 1 |
← Previous Page 5 of 5
← Back to Gabelli 2025-2026 overview
Built October 25, 2026 from SEC Form N-PX filings.